Access to anti-retroviral drugs, male in Mexico
Mexico: Access to anti-retroviral drugs, male was 67.0% in 2024. ▲ Rising
Access to anti-retroviral drugs, male in Mexico, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
The most recent figure for access to anti-retroviral drugs, male in Mexico is 67.0%, measured in 2024. That is the highest value across all 25 years on record.
The figure is up 3.1% on the previous year and up 86.1% over ten years.
Over the whole period, access to anti-retroviral drugs, male in Mexico peaked at 67.0% in 2024 and was at its lowest, 9.0%, in 2000.
That places Mexico 78th out of 141 countries with data for 2024, putting it in the middle of the range.
The long-run direction has been consistently rising across the 25 years of available data.
Access to anti-retroviral drugs, male in Mexico, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 9.0% | — |
| 2001 | 11.0% | +22.2% |
| 2002 | 14.0% | +27.3% |
| 2003 | 18.0% | +28.6% |
| 2004 | 19.0% | +5.6% |
| 2005 | 21.0% | +10.5% |
| 2006 | 24.0% | +14.3% |
| 2007 | 26.0% | +8.3% |
| 2008 | 28.0% | +7.7% |
| 2009 | 30.0% | +7.1% |
| 2010 | 30.0% | +0.0% |
| 2011 | 32.0% | +6.7% |
| 2012 | 33.0% | +3.1% |
| 2013 | 34.0% | +3.0% |
| 2014 | 36.0% | +5.9% |
| 2015 | 41.0% | +13.9% |
| 2016 | 45.0% | +9.8% |
| 2017 | 46.0% | +2.2% |
| 2018 | 53.0% | +15.2% |
| 2019 | 53.0% | +0.0% |
| 2020 | 59.0% | +11.3% |
| 2021 | 62.0% | +5.1% |
| 2022 | 63.0% | +1.6% |
| 2023 | 65.0% | +3.2% |
| 2024 | 67.0% | +3.1% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 20.0% | 9.0% | 30.0% | 10 |
| 2010s | 40.3% | 30.0% | 53.0% | 10 |
| 2020s | 63.2% | 59.0% | 67.0% | 5 |
Countries ranked near Mexico
More gender data for Mexico
- Child population (UN estimates and projections) 30,197 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -0.9402 % change on previous year (2030)
- Population 106,708 (2030)
- Working-age population (UN estimates and projections) 106,708 (2030)
- Population (UN estimates and projections), annual growth rate 1.16 % change on previous year (2030)
- Age population, age 00, female, interpolated 978,858 (2025)
- Age population, age 00, male, interpolated 1.01 million (2025)
- Age population, age 01, female, interpolated 984,557 (2025)
- Age population, age 01, male, interpolated 1.02 million (2025)
- Age population, age 02, female, interpolated 992,716 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, male in Mexico?
- Access to anti-retroviral drugs, male in Mexico was 67.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, male recorded in Mexico?
- The highest recorded value was 67.0% in 2024.
- What is the lowest access to anti-retroviral drugs, male recorded in Mexico?
- The lowest recorded value was 9.0% in 2000.
- How does Mexico rank for access to anti-retroviral drugs, male?
- Mexico ranks 78th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, male rising or falling in Mexico?
- Over the last ten years it is up 86.1%. The long-run trend across the full record is rising.
- Where does this Mexico data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.